GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. (Q48592516)
Jump to navigation
Jump to search
scientific article published on 29 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. |
scientific article published on 29 July 2009 |
Statements
1 reference
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. (English)
1 reference
Claus Cursiefen
1 reference
Berthold Seitz
1 reference
Felix Bock
1 reference
Folkert K Horn
1 reference
Friedrich E Kruse
1 reference
Vincent Borderie
1 reference
Beatrice Früh
1 reference
Michael A Thiel
1 reference
Frank Wilhelm
1 reference
Bernard Geudelin
1 reference
Isabelle Descohand
1 reference
Klaus-Peter Steuhl
1 reference
Angela Hahn
1 reference
Daniel Meller
1 reference
29 July 2009
1 reference
1 reference
116
1 reference
9
1 reference
1630-1637
1 reference